Rifaximin versus herbal antimicrobials for small intestinal bacterial overgrowth
Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, Justino E, Tomakin E, Mullin GE
Published in Global Advances in Health and Medicine
Methodology
Retrospective comparative study of herbal antimicrobial therapy versus rifaximin in patients with SIBO confirmed by lactulose breath testing.
Key Findings
Herbal antimicrobials achieved breath-test normalisation in 46% of patients compared with 34% for rifaximin.
Conclusions
Botanical antimicrobials are a plausible option for SIBO management.
Limitations
Retrospective, non-randomised, single centre.
Supplements Studied
Herbal antimicrobials achieved breath-test normalisation in 46% of patients compared with 34% for rifaximin
Outcomes Measured
Herbal antimicrobials achieved breath-test normalisation in 46% of patients compared with 34% for rifaximin
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.